Nitric oxide facilitates the targeting Kupffer cells of a nano-antioxidant for the treatment of NASH
Hitoshi Maeda(Kyoto Pharmaceutical University), Toru Maruyama(Kumamoto University), Kengo Yasuda(Kumamoto University), Kayoko Sonoda(Kumamoto University), Junji Saruwatari(Kumamoto University), Kentaro Oniki(Kumamoto University), Masaki Otagiri(Sojo University), Shun Oshiro(Kumamoto University), Taisei Nagasaki(Kumamoto University), Yuki Mizuta(Kumamoto University), Yuki Minayoshi(Kumamoto University), Yutaka Sasaki(Iwate Medical University), Hirofumi Kai(Kumamoto University), Tsuyoshi Shuto(Kumamoto University), Hiroshi Watanabe(Tohoku University), Tomohiko Wakayama(Kumamoto University), Manabu Kinoshita(Asahikawa Medical University), Shota Ichimizu(Kumamoto University), Yu Ishima(Kyoto Pharmaceutical University), Yasuko Iwakiri(Yale University), Hiroki Yanagisawa(Kumamoto University), Manabu Taura(Yale University), Motohiko Tanaka(Kumamoto University), Matthew J. McConnell(Yale University)
Cited by 19
Related Papers
Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2
|New England Journal of Medicine|2020|1k
Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT–qPCR primer–probe sets
|Nature Microbiology|2020|917
Prospective Phase II Study of Gefitinib for Chemotherapy-Naïve Patients With Advanced Non–Small-Cell Lung Cancer With Epidermal Growth Factor Receptor Gene Mutations
|Journal of Clinical Oncology|2006|504